PepStackOverflow
PepStackOverflowPremium Peptides
Contact
Cagrilintide Research Guide

Cagrilintide

An amylin analogue under clinical investigation for appetite regulation and metabolic health. Human use should be discussed with a licensed clinician.

Vial size
5 mg
Benefits
2 listed
Route
Subcutaneous
Cycle break
Clinician directed

Potential Benefits

Key advantages and therapeutic effects

1

Appetite Regulation

  • Studied for effects on hunger and satiety
  • May support reduced food intake in clinical research
  • Acts through amylin receptor pathways
2

Metabolic Research

  • Investigated as a potential weight-management therapy
  • Also studied in combination with GLP-1 medicines
  • Clinical evidence and regulatory status continue to develop

Injection Guide

Step-by-step subcutaneous administration

Injection Sites

Recommended locations for administration

Subcutaneous injection sites diagram showing front and back view of human body with highlighted injection areas at upper arms, abdomen, and thighs

Rotate injection sites each week to keep skin healthy and medication effective. Avoid areas that are scarred, bruised, or irritated.

Dosing Guide

Calculate your dose - consult your healthcare provider

Dosage Calculator

Calculate your insulin syringe units

Total peptide in vial

Amount of water added

Amount you want to inject

Draw this amount on your syringe:

40 units

Concentration: 2.5 mg/mL

Cagrilintide is investigational and there is no generally established self-administration dose. Do not use this page to select a dose; consult a licensed healthcare professional and follow applicable clinical guidance.

Suggested Dosage: Cagrilintide

General reference only. Consult your physician.

Starting DoseTypical RangeUpper-End / Max
Not established
Not established
Not established
Starting Dose

Not established

Typical Range

Not established

Upper-End / Max

Not established

Cagrilintide is investigational and there is no generally established self-administration dose. Do not use this page to select a dose; consult a licensed healthcare professional and follow applicable clinical guidance.

Side Effects

Potential adverse reactions to be aware of

Potential Side Effects

  • Nausea or vomiting
  • Reduced appetite
  • Constipation or diarrhea
  • Injection-site reactions
  • Seek urgent medical care for signs of a serious allergic reaction

Cycle Information

Recommended timing between cycles

Clinician directed

(Investigational compound; no standard cycle is established)